Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antiviralsAnita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.
Nature Genetics|April 11, 2017
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosisMohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, et al.
Nature Communications|September 16, 2016
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis CKhaled Thabet, Anastasia Asimakopoulos, Maryam Shojaei, et al.
Nature Communications|March 6, 2015
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseMohammed Eslam, Ahmed M Hashem, Reynold Leung, et al.
Journal of Hepatology|November 24, 2015
FibroGENE: A gene-based model for staging liver fibrosisMohammed Eslam, Ahmed M Hashem, Manuel Romero-Gomez, et al.
Hepatology (Baltimore, Md.)|January 30, 2016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypesMohammed Eslam, Alessandra Mangia, Thomas Berg, et al.
Eclinicalmedicine|September 18, 2023
Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trialLaure F Pittet, Cecilia L Moore, Ellie McDonald, et al.
Scientific Reports|February 7, 2019
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanismsRasha El Sharkawy, Ali Bayoumi, Mayada Metwally, et al.
Nature Medicine|November 7, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trialGrace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin, et al.
Pageof 8